Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy
Stephen P. Chelko(Florida State University), Daniel P. Judge(Medical University of South Carolina)
Cited by 177
Related Papers
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy
|New England Journal of Medicine|2024|453
Efficacy and safety of tafamidis doses in the <scp>Tafamidis in Transthyretin Cardiomyopathy Clinical Trial</scp> ( <scp>ATTR‐ACT</scp> ) and long‐term extension study
|European Journal of Heart Failure|2020|207
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy
|Circulation|2021|181
Genetic Testing for Dilated Cardiomyopathy in Clinical Practice
|Journal of Cardiac Failure|2012|163